Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_12810 | 194 | 4.04 | Mlig455_069903 | Neo: Irradiation Age: Up-Up-Down, logFC(26M/2M)=0.220 Region-enriched R5: 2.094/0.01518 |
Mlig455_069903 {REF} {Length: 4228} {TRANSSPLICED} {Pfam: HAP1 N-terminal conserved region [PF04849.15, score=20.9]} {RNA1509_14533} {RNA1310_10263.1, RNA1509_14533} {RNA1509_14533, RNA815_2693.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.079 | 2.816 | 0.98518 | 1.00000 | |
RegionR2 | 2.418 | 2.816 | 0.02276 | 0.16697 | |
RegionR3 | 0.134 | 2.816 | 0.73163 | 1.00000 | |
RegionR4 | -0.267 | 2.816 | 0.89825 | 1.00000 | |
RegionR5 | 2.094 | 2.816 | 0.00166 | 0.01518 | |
RegionR6 | 0.98 | 2.816 | 0.23860 | 0.82257 | |
RegionR7 | 0.704 | 2.816 | 0.48118 | 1.00000 | |
RegionR8 | -4.985 | 2.816 | 0.12133 | 0.64073 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 2.998 | 2.816 | 0.30698 | 1.00000 | |
RegenerationR2 | 0.496 | 2.816 | 0.57135 | 0.90272 | |
RegenerationR3 | 1.707 | 2.816 | 0.06154 | 0.42025 | |
RegenerationR4 | 0.45 | 2.816 | 0.57815 | 0.90473 | |
RegenerationR5 | 0.13 | 2.816 | 0.80114 | 0.98891 | |
RegenerationR6 | 0.492 | 2.816 | 0.61070 | 0.87469 | |
RegenerationBL | 0.817 | 2.816 | 0.68523 | 1.00000 | |
RegenerationTP | 3.072 | 2.816 | 0.16928 | 0.60200 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_12810 | 194 | 4.04 | Mlig455_069903 | Neo: Irradiation Age: Up-Up-Down, logFC(26M/2M)=0.220 Region-enriched R5: 2.094/0.01518 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_069903 {REF} {Length: 4228} {TRANSSPLICED} {Pfam: HAP1 N-terminal conserved region [PF04849.15, score=20.9]} {RNA1509_14533} {RNA1310_10263.1, RNA1509_14533} {RNA1509_14533, RNA815_2693.1} | |
2. | MligTC455_12809 | 506 | 10.55 | Mlig455_037639 | Neo: Int S/G2/M Age: logFC(26M/2M)=0.705 Region-enriched R5: 1.347/0.01568 |
2.774 | 0.990 | 0.958 | - | - | - | 0.826 | Mlig455_037639 {REF} {Length: 2516} {TRANSSPLICED} {Pfam: HAP1 N-terminal conserved region [PF04849.15, score=20.9]} {RNA1509_14533} {RNA1310_10263.1} {RNA815_2693.1} | |
3. | MligTC455_51883 | 225 | 4.68 | Mlig455_038026, Mlig455_038936 | Neo: Irradiation Age: - Region-enriched R5: 4.340/0.02386 |
GLRA2 | 2.516 | 0.787 | - | 0.751 | - | - | 0.978 | Mlig455_038026 {REF} {Length: 2683} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=127.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=288, Expect=3e-92]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=279, Expect=8e-89]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=276, Expect=8e-88]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=285, Expect=3e-91]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=278, Expect=3e-88]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=273, Expect=1e-86]} {Dmel: FBgn0024963, GluClalpha, [Score=275, Expect=1e-87]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [RH, Score=269, Expect=5e-85]} {Smed: dd_Smed_v6_18238_0_1, dd_Smed_v6_18238_0_1, [Score=239, Expect=5e-74]} {RNA1509_53717} {RNA1310_10428.1} {RNA815_24141} Mlig455_038936 {REF} {Length: 6984} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=127.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=288, Expect=3e-92]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=279, Expect=8e-89]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=276, Expect=8e-88]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=285, Expect=3e-91]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=278, Expect=3e-88]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=273, Expect=1e-86]} {Dmel: FBgn0024963, GluClalpha, [Score=275, Expect=1e-87]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [RH, Score=269, Expect=5e-85]} {Smed: dd_Smed_v6_18238_0_1, dd_Smed_v6_18238_0_1, [Score=239, Expect=5e-74]} {RNA1509_53717} {RNA1310_10428.1} {RNA815_24141} |
4. | MligTC455_47350 | 121 | 2.53 | Mlig455_061845 | Neo: - Age: - |
DNMT3B | 1.785 | - | - | - | 0.820 | 0.965 | - | Mlig455_061845 {REF} {Length: 2275} {TRANSSPLICED} {Pfam: Cysteine rich ADD domain in DNMT3 [PF17980.3, score=29.7]} {Human: ENSG00000088305, DNMT3B, DNA methyltransferase 3 beta, [Score=89.0, Expect=1e-17]} {Mouse: ENSMUSG00000027478, Dnmt3b, DNA methyltransferase 3B, [Score=97.1, Expect=2e-20]; ENSMUSG00000082079, Dnmt3c, DNA methyltransferase 3C, [Score=94.7, Expect=1e-19]} {RNA1509_22614, RNA1509_23149} {RNA1310_10697.1, RNA1509_22614} {RNA1509_22614, RNA815_14886} |
5. | MligTC455_14662 | 19 | 0.39 | Mlig455_003504 | Neo: - Age: - |
1.701 | - | 0.728 | - | - | - | 0.973 | Mlig455_003504 {REF} {Length: 460} {NoTransDecoderORF} {RNA1310_108617} | |
6. | MligTC455_12790 | 14 | 0.28 | Mlig455_018710, Mlig455_018746, Mlig455_018914 | Neo: - Age: - Regeneration-enriched R3: 8.221 |
0.964 | - | - | - | - | - | 0.964 | Mlig455_018710 {REF} {Length: 435} Mlig455_018746 {REF} {Length: 391} {RNA1310_101839} {RNA815_52263} Mlig455_018914 {REF} {Length: 552} |
|
7. | MligTC455_21583 | 64 | 1.33 | Mlig455_001407, Mlig455_064265 | Neo: - Age: - |
PDE8A | 0.959 | - | - | - | - | - | 0.959 | Mlig455_001407 {REF} {Length: 4083} {TRANSSPLICED} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=278.7]; PAS domain [PF13426.9, score=22.9]} {Human: ENSG00000073417, PDE8A, phosphodiesterase 8A, [Score=589, Expect=0.0]; ENSG00000113231, PDE8B, phosphodiesterase 8B, [Score=568, Expect=0.0]; ENSG00000284762, AC022414.1, phosphodiesterase 8B, [Score=565, Expect=0.0]} {Mouse: ENSMUSG00000025584, Pde8a, phosphodiesterase 8A, [Score=579, Expect=0.0]; ENSMUSG00000021684, Pde8b, phosphodiesterase 8B, [Score=569, Expect=0.0]} {Dmel: FBgn0266377, Pde8, Phosphodiesterase 8, [Score=357, Expect=4e-110]} {Celegans: WBGene00022389, pde-6, Probable 3',5'-cyclic phosphodiesterase pde-6, [RH, Score=312, Expect=6e-94]} {Smed: dd_Smed_v6_10593_0_1, dd_Smed_v6_10593_0_1, [Score=410, Expect=2e-130]} {RNA1509_38664} {RNA1310_9544} {RNA815_9009} Mlig455_064265 {REF} {Length: 3769} {TRANSSPLICED} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=279.8]} {Human: ENSG00000073417, PDE8A, phosphodiesterase 8A, [Score=519, Expect=2e-172]; ENSG00000113231, PDE8B, phosphodiesterase 8B, [Score=495, Expect=4e-162]} {Mouse: ENSMUSG00000025584, Pde8a, phosphodiesterase 8A, [Score=499, Expect=1e-164]; ENSMUSG00000021684, Pde8b, phosphodiesterase 8B, [Score=496, Expect=8e-164]} {Dmel: FBgn0266377, Pde8, Phosphodiesterase 8, [Score=361, Expect=5e-112]} {Celegans: WBGene00022389, pde-6, Probable 3',5'-cyclic phosphodiesterase pde-6, [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_10593_0_2, dd_Smed_v6_10593_0_2, [Score=404, Expect=1e-128]} {RNA1509_38664} {RNA1310_9544} {RNA815_9009} |